You just read:

Fractyl Announces Initiation of Multicenter Clinical Trial to Evaluate a Novel Medical Procedure for Poorly Controlled Type 2 Diabetes

News provided by

Fractyl Laboratories Inc.

23 May, 2017, 08:00 ET